Galya Blachman
General Counsel bei 501 ACQU
Profil
Galya D.
Blachman is currently working as a Legal Advisor at 5AM Venture Management LLC since 2022, as Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020, as General Counsel at Biotech Connection-Bay Area, Inc. since 2018, and as Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. Galya's former job was as a Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Dr. Blachman completed their education at the University of Oxford with a graduate degree in 2009, the University of Cambridge with a doctorate degree in 2004, the University of Cape Town with an undergraduate degree in 2000 and a graduate degree in 2001, and BPP Law School with a graduate degree in 2006.
Aktive Positionen von Galya Blachman
| Unternehmen | Position | Beginn |
|---|---|---|
| 501 ACQU | General Counsel | 01.09.2020 |
| ENLIVEN THERAPEUTICS, INC. | General Counsel | 01.04.2020 |
| Biotech Connection-Bay Area, Inc. | General Counsel | 01.06.2018 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | General Counsel | 01.09.2018 |
Ehemalige bekannte Positionen von Galya Blachman
| Unternehmen | Position | Ende |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | General Counsel | 01.01.2017 |
Ausbildung von Galya Blachman
| University of Oxford | Graduate Degree |
| University of Cambridge | Doctorate Degree |
| University of Cape Town | Graduate Degree |
| BPP Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
| Biotech Connection-Bay Area, Inc. |
